Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours
about
Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers.Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.Adding value through accelerator mass spectrometry-enabled first in human studies.Population pharmacokinetics and exposure-response of trametinib, a MEK inhibitor, in patients with BRAF V600 mutation-positive melanoma.Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approachesNext-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients.Application of (14)C-accelerator MS in pharmaceutical development.Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells.
P2860
Q38527478-29857F19-7413-4702-B1A3-04AC6BFCB87DQ38849629-8B22CB0F-5672-4FED-A061-FD343FE5174EQ39573778-55466991-CD11-4CEB-87BA-A649A8B1ADFEQ40872819-A5B26067-D9E5-4C24-A72F-31F20B50B50DQ41880361-2CED3453-63C9-499C-9153-9B84957D5457Q46538042-2454984E-751D-4449-80AC-2D17282BE25BQ48172142-C7BCE3D8-1136-43A8-BCD2-D51D94E37D37Q53226670-3B7EB8C0-7AB9-4530-AA7A-B818082B4696Q54117167-87B143DB-6AA7-4918-AE72-48294BCF5DB5
P2860
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Concomitant oral and intraveno ...... in subjects with solid tumours
@ast
Concomitant oral and intraveno ...... in subjects with solid tumours
@en
Concomitant oral and intraveno ...... in subjects with solid tumours
@nl
type
label
Concomitant oral and intraveno ...... in subjects with solid tumours
@ast
Concomitant oral and intraveno ...... in subjects with solid tumours
@en
Concomitant oral and intraveno ...... in subjects with solid tumours
@nl
prefLabel
Concomitant oral and intraveno ...... in subjects with solid tumours
@ast
Concomitant oral and intraveno ...... in subjects with solid tumours
@en
Concomitant oral and intraveno ...... in subjects with solid tumours
@nl
P2093
P2860
P356
P1476
Concomitant oral and intraveno ...... in subjects with solid tumours
@en
P2093
Carolyn Pendry
Cathrine Leonowens
Daniele Ouellet
Frank Henriquez
Graeme C Young
John Bauman
Keith Orford
Royce A Morrison
P2860
P304
P356
10.1111/BCP.12373
P407
P577
2014-09-01T00:00:00Z